Fibroids. Very Common! Benign smooth muscle tumors of the myometrium 20-80% of women develop fibroids by age 50* 151 million women affected**

Similar documents
Management of Uterine Myomas

4 Proven Ways of How To Treat Fibroids Naturally

CLEAR COVERAGE HYSTERECTOMY CHECKLISTS

Not all roads point to hysterectomy: treatment options for fibroids

Uterine artery embolisation for treating adenomyosis

UTERINE FIBROID EMBOLIZATION

Conflicts 10/5/2016. Abnormal Uterine Bleeding. Objectives Review diagnosis and updated nomenclature. Management options for acute and chronic AUB.

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

REPROS THERAPEUTICS. Dedicated to Treating Male and Female Reproductive Disorders. Corporate Presentation. August 2017

REPROS THERAPEUTICS. Dedicated to Treating Male and Female Reproductive Disorders. Corporate Presentation. September 2017

Excessive menstrual blood loss

5/5/2010 FINANCIAL DISCLOSURE. Abnormal Uterine Bleeding. Is This A Problem? About me % of visits to gynecologist

Chronic Pelvic Pain Case Study

Fibroid mapping. Haitham Hamoda MD FRCOG Consultant Gynaecologist, Subspecialist in Reproductive Medicine & Surgery King s College Hospital

Heavy Menstrual Bleeding. Mr Nick Nicholas MD FRCOG Grad Dip Law. Consultant Gynaecologist

Menstrual Disorders & Ambulatory Gynaecology

Patient Input CADTH COMMON DRUG REVIEW. ulipristal acetate (Fibristal) (Allergan Inc.) Indication: Uterine fibroids (signs and symptoms)

Abnormal Uterine Bleeding Case Studies

Gynecologic Decision Making Based on Sonographic Findings

Uterine-Sparing Treatment Options for Symptomatic Uterine Fibroids

Perimenopausal DUB. Mary Anne Jamieson, MD Associate Professor, OB/GYN Queen s University Kingston, Ontario

Frequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.


Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre

Freedom of Information

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine

Center for Menstrual Disorders, Fibroids and Hysteroscopic Services

An MRI pictorial review of uterine fibroid expulsion after uterine artery embolisation

University Gynecologic Oncology Associates

Michael Meuse, MD Vascular and Interventional Radiology

Clinical Efficacy and Complications of Uterine Artery Embolization in Symptomatic Uterine Fibroids

Investigating HMB- an evidence based approach

PALM-COEIN: Your AUB Counseling Guide

International Journal of Scientific Research and Reviews

Abnormal uterine bleeding:

Contraception and gynecological pathologies

Uterine artery embolization for symptomatic uterine fibroids(review)

Abnormal Uterine Bleeding: Evaluation of Premenopausal Women. Vanessa Jacoby, MD, MAS Assistant Professor Ob, Gyn, & Reproductive Sciences UCSF

THE RECOVERY PROCESS FOLLOW-UP CARE

MEDICAL POLICY SUBJECT: ENDOMETRIAL ABLATION

Laparoscopic Hysterectomy

Post-Procedure Care and Same-Day PCI. Arnold Seto, MD, MPA

Modern Management of Fibroids

Laparoscopy. What is Laparoscopy? Why is this surgery used? How do I prepare for surgery?

Index. Note: Page numbers of article titles are in boldface type.

The Centre for Reproductive Medicine HYSTERECTOMY

Hysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment

Robot Assisted Total Laparoscopic Hysterectomy

COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS, SINGAPORE 2006

Fibroid Tumors And Endometriosis By Susan M. Lark READ ONLINE

PATIENT GROUP CONDEMNS NICE REVISED HEAVY MENSTRUAL BLEEDING GUIDELINES UNSAFE FOR WOMEN MANY MORE WOMEN WILL DIE AND SUFFER SERIOUS COMPLICATIONS

Considering Surgery for Fibroids? Learn about minimally invasive da Vinci Surgery

Medical Management of Fibroids Esmya. Dr Paula Briggs Consultant in Sexual and Reproductive Health

Elaina Sexton, MD, MSc Obstetrics and Gynecology St. Vincent s Hospital. Objectives

POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist

ORILISSA (elagolix) oral tablet

Prevention, Diagnosis and Treatment of Gynecologic Cancers

ANEMIA AND HEAVY MENSTRUAL BLEEDING

Chapter 100 Gynecologic Disorders

Management of Abnormal Uterine Bleeding. Julie Strickland MD, MPH University of Missouri Kansas City Department of Obstetrics and Gynecology

6/24/2013. John C. Lipman, MD, FACR, FSIR Atlanta, Georgia. Disclosure. Educational grant: Merit Medical, Boston Scientific

Endometrial Stromal Sarcoma

Shift your surgical ambition to surgical action

Dysmenorrhea. Erin Eppsteiner, M.D. Department of Ob/Gyn The University of Iowa Roy J & Lucille A Carver College of Medicine

Chronic Pelvic Pain. Bridget Kamen, MD Obstetrics and Gynecology, Confluence Health. I have no disclosures

Hysteroscopy. Department of Gynaecology. Patient information

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation

Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages

Hysterectomy : A Clinicopathologic Correlation

Standardized Nurse Activated Protocols (SNAPs)

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use

Primary Care Gynaecology Guidelines: HEAVY REGULAR MENSTRUAL BLEEDING

Metro Acupuncture 6255 Barfield Road, Suite 175 Atlanta, GA

Update on Medical and Surgical Therapy Sara Jane Pieper, MD Chair, Gynecology Development Team

INTERVENTIONAL PROCEDURES PROGRAMME

A Practitioner s Toolkit for the Management of the Menopause

Types of Hysterectomy for Non-cancerous Conditions: Understanding Your Doctor s Recommendations

Laparoscopy and Hysteroscopy

WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT OGEN (AN ESTROGEN HORMONE)?

After Uterine Artery Embolization

100% Highly effective No cost No side effects

World Health Organization Medical Eligibility for Contraceptive Use. Connie Kraus, PharmD, BCACP Professor (CHS) Director Office of Global Health

Dr Mary Birdsall. Fertility Associates Auckland

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health and social care directorate. Quality standards and indicators.

Patient Health Forms

MRI-Guided Focused Ultrasound (MRgFUS) for thetreatment of Uterine Fibroids and Other Tumors. Original Policy Date

PRE-ASS ESSMENT. Endometrial Ablation for Menorrhagia

What is endometrial cancer?

Levosert levonorgestrel 20mcg/24hour intrauterine device

Gayatrri Anipindi *, Vani I. Original Research Article. Abstract

Patient Education. Ultrasound

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Pelvic Pain/Endometriosis Year 3 Updated April 2017 By Dr. J. N. Kirby

Management of Uterine Fibroids: An Update of the Evidence

Cath Conference Kintur Sanghvi MD March 15, 2007

Other physician #1. #(p) List any allergies to medications. Please list below all other current medical conditions or previous surgeries

AGENDA. Mode of action and application of SPRMs in the treatment of uterine fibroids N. Chabbert Buffet

Pelvic Pain. What you need to know. 139 Dumaresq Street Campbelltown Phone Fax

Transcription:

Fibroids Very Common! Benign smooth muscle tumors of the myometrium 20-80% of women develop fibroids by age 50* 151 million women affected** * Uterine Fibroids Fact Sheet Office on Women s Health 2015 ** Global Burden of Disease Study 2015 Lancet Oct 2016

Fibroids Only treat when symptomatic Symptoms Heavy menstrual bleeding (w or w/o anemia) Bulk symptoms such as Pelvic pain, pressure Urinary frequency, hesitancy, retention Painful intercourse Constipation Back, flank or leg pain

Treatment of Fibroids Medical NSAIDS Iron (if anemic) Other Medications: Birth Control Hormones, Gonadotropinreleasing hormone agonists (Lupron) and antagonists (Elagolix), etc. IUD (progestin-releasing) Minimally Invasive MRI-guided focused ultrasound UFE (Uterine Fibroid Embolization) Endometrial Ablation Surgical Hysteroscopic Fibroid Removal Myomectomy Laproscopic RFA Fibroids Hysterectomy

Uterine Fibroid Embolization Proven with subjective and objective data Developed in the late 1990s Continues to improve Outpatient minimally invasive procedure Treats ALL of the fibroids Optimum next option for those who have failed conservative medical measures

Uterine Fibroid Embolization Success is high and complications are low Success: 90% satisfied w/ bleeding sx @1 yr & 80% satisfied w/ bulk sx @ 1 yr: Summary data 86% satisfied at 3 years: Fibroid registry 78% satisfied @10 years: EMMY trial 40-70%: Shrinkage of each fibroid and the uterus measured at 6 mo MRI Large Fibroids >10 cm can be treated successfully without increased complication

Uterine Fibroid Embolization Successfully treated fibroids progressively reduce in volume over time, beyond 6 months

Complications Permanent amenorrhea < 45y 0-3%; >45y 20-40% Prolonged vaginal discharge 2-17% Transcervical leiomyoma expulsion 3-15% Sepsis 1-3% DVT/PE <1% Non-target embolization <1% Standards of Practice: Quality Improvement Guidelines for Uterine Artery Embolization for Symptomatic Leiomyomas JVIR AUG 2010

Uterine Fibroid Embolization Pre-Procedure Evaluation Clinical History and Physical Exam (w Barbeau test) UFS-QOL score (Uterine Fibroid Symptom and Quality of Life Evaluation) Prior medical care: Up to date pap smear, mammogram, etc Labs: FSH, CBC, Creatinine, Coags, LD isozymes, poss AMH, poss preg test, etc. Imaging: MRI with Gadolinium Endometrial bx: Not essential unless other worrisome features

Target Uterine Arteries via Radial Artery

UFE technique Pre-procedure meds: Scopolamine patch, IV acetaminophen, IV Ibuprofen, IV Ancef, EMLA cream and Nitro paste on left wrist Pre-procedure nerve block: Superior Hypogastric Nerve Block Intra-procedure meds: Zofran, Versed, Fentanyl, Dexamethasone, IA lidocaine 1% Entry: Left radial artery with ultrasound guidance Place left radial artery 4F sheath Select both uterine arteries w/ small 4F & micro catheters Embolize with 500-700 micron Tris-Acryl or PVA particles (sometimes +/- particle size) Apply Stat seal and TR compression band to wrist after removal of catheter/sheath

UFE Technique Radial artery entry..(vs femoral) No closure device or manual compression needed No foley Easier in obese patients Patients can walk immediately which decreases risk of DVT No sequential compression devices for DVT prevention Easier if there is nausea or vomiting Patients love it! Radial entry preferred over femoral entry* *Fischman, A et al. Uterine Artery Embolization Using a Transradial Approach: Initial Experience and Technique; JVIR 2014 Cooper, CJ et al. Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison ; AHJ 1999

Fibroids can rarely have ovarian artery supply, too, which can be embolized if needed

Uterine Fibroid Embolization Post Procedure Care Control pain and nausea which is greatest in the first 6-12 hours Anti-emetic medications: Scopolamine patch, Ondansetron (Zofran) IV Pain medications: Opioids po or IV Ambulation, which is easy with radial artery entry Discharge: po NSAIDS and stool softeners PRN Anti-emetics and opioids f/u IR clinic 2 weeks

Sample Case: Radial Uterine Artery Embolization with Pre-procedure Superior Hypogastric Nerve Block

MRI Images Before and After UFE

PRE POST

Pre 16 months Post

Pre 8 months post

Pre 8 mo post

Pre 3 years post

1 year 3 years

PRE POST

Before UAE After UAE

Pre History of significant retention Post

Conclusions UFE is a well established effective non-surgical minimally invasive outpatient option for fibroid patients that have significant bulk and/or bleeding symptoms Fibroids shrink 40-70% (measured by MRI at 6 mo) and they continue to shrink for years Large fibroids can be treated without increased risk or pain

Conclusions Radial artery entry has numerous benefits including improved patient comfort and satisfaction with the procedure UFE is a good option for patients with adenomyosis as well as fibroids UFE is a great next step if more conservative medical options have failed.